The following financial or other conflicts of interest cover the period 12 months before December 2017
| Member . | Employment . | Research grant . | Other research support . |
|---|---|---|---|
| Rita R. Kalyani, MD, MHS, FACP (Chair) | Johns Hopkins University, Baltimore, MD | None | None |
| Christopher P. Cannon, MD | Brigham and Women's Hospital, Boston, MA | Amgen, Arisaph, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, Janssen, Merck, Takeda | None |
| Andrea L. Cherrington, MD, MPH | University of Alabama, Birmingham, AL | None | None |
| Donald R. Coustan, MD | The Warren Alpert Medical School of Brown University, Providence, RI | None | None |
| Ian H. de Boer, MD, MS | University of Washington, Seattle, WA | Research grant from ADA | Medtronic, |
| Abbott | |||
| Hope Feldman, CRNP, FNP-BC | Abbottsford-Falls Family Practice & Counseling, Philadelphia, PA | None | None |
| Judith Fradkin, MD | National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD | None | None |
| David Maahs, MD, PhD | Stanford University, School of Medicine, Stanford, CA | Medtronic, Dexcom, Roche, Insulet, Bigfoot | None |
| Melinda Maryniuk, MEd, RD, CDE | Joslin Diabetes Center, Boston, MA | None | None |
| Medha N. Munshi, MD | Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA | None | Common Sensing |
| Joshua J. Neumiller, PharmD, CDE, FASCP | Washington State University, Spokane, WA | None | None |
| Guillermo E. Umpierrez, MD, CDE, FACE, FACP | Emory University, Atlanta, GA | Sanofi, Novo Nordisk, Merck, Boehringer Ingelheim, AstraZeneca | None |
| Sandeep Das, MD, MPH^ | University of Texas Southwestern Medical Center | None | None |
| Mikhail Kosiborod, MD^ | University of Missouri-Kansas City School of Medicine | None | None |
| William T. Cefalu, MD (Staff)† | American Diabetes Association, Arlington, VA | Sanofi*# | None |
| Erika Gebel Berg, PhD (Staff) | American Diabetes Association, Arlington, VA | None | None |
| Tamara Darsow, PhD (Staff) | American Diabetes Association, Arlington, VA | None | None |
| Matthew P. Petersen (Staff) | American Diabetes Association, Arlington, VA | None | None |
| Sacha Uelmen, RDN, CDE (Staff) | American Diabetes Association, Arlington, VA | None | None |
| Member . | Employment . | Research grant . | Other research support . |
|---|---|---|---|
| Rita R. Kalyani, MD, MHS, FACP (Chair) | Johns Hopkins University, Baltimore, MD | None | None |
| Christopher P. Cannon, MD | Brigham and Women's Hospital, Boston, MA | Amgen, Arisaph, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, Janssen, Merck, Takeda | None |
| Andrea L. Cherrington, MD, MPH | University of Alabama, Birmingham, AL | None | None |
| Donald R. Coustan, MD | The Warren Alpert Medical School of Brown University, Providence, RI | None | None |
| Ian H. de Boer, MD, MS | University of Washington, Seattle, WA | Research grant from ADA | Medtronic, |
| Abbott | |||
| Hope Feldman, CRNP, FNP-BC | Abbottsford-Falls Family Practice & Counseling, Philadelphia, PA | None | None |
| Judith Fradkin, MD | National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD | None | None |
| David Maahs, MD, PhD | Stanford University, School of Medicine, Stanford, CA | Medtronic, Dexcom, Roche, Insulet, Bigfoot | None |
| Melinda Maryniuk, MEd, RD, CDE | Joslin Diabetes Center, Boston, MA | None | None |
| Medha N. Munshi, MD | Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA | None | Common Sensing |
| Joshua J. Neumiller, PharmD, CDE, FASCP | Washington State University, Spokane, WA | None | None |
| Guillermo E. Umpierrez, MD, CDE, FACE, FACP | Emory University, Atlanta, GA | Sanofi, Novo Nordisk, Merck, Boehringer Ingelheim, AstraZeneca | None |
| Sandeep Das, MD, MPH^ | University of Texas Southwestern Medical Center | None | None |
| Mikhail Kosiborod, MD^ | University of Missouri-Kansas City School of Medicine | None | None |
| William T. Cefalu, MD (Staff)† | American Diabetes Association, Arlington, VA | Sanofi*# | None |
| Erika Gebel Berg, PhD (Staff) | American Diabetes Association, Arlington, VA | None | None |
| Tamara Darsow, PhD (Staff) | American Diabetes Association, Arlington, VA | None | None |
| Matthew P. Petersen (Staff) | American Diabetes Association, Arlington, VA | None | None |
| Sacha Uelmen, RDN, CDE (Staff) | American Diabetes Association, Arlington, VA | None | None |
| Member . | Speakers’ bureau/honoraria . | Ownership interest . | Consultant/advisory board . | Other . |
|---|---|---|---|---|
| R.R.K. | None | None | None | None |
| C.P.C. | None | None | Alnylam, Amarin, Amgen, Arisaph, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Eisai, GlaxoSmithKline, Kowa, Lipimedix, Merck, Pfizer, Regeneron, Sanofi, Takeda | None |
| A.L.C. | AstraZeneca (Women Scientists Board) | Connection Health (Volunteer Chief Medical Officer) | None | Coinvestigator, drug study by Merck Sharp & Dohme; |
| Site investigator, drug study by Boehringer Ingelheim | ||||
| D.R.C. | None | None | None | None |
| I.H.d.B. | None | None | Boehringer Ingelheim, Janssen, Ironwood | None |
| H.F. | None | None | None | Member, American Diabetes Association Primary Care Advisory Group; |
| Member, Diabetes Spectrum Editorial Board | ||||
| J.F. | None | None | None | None |
| D.M. | None | None | Insulet, Helmsely Charitable Trust | Editorial Boards, The Journal of Pediatrics and Diabetes Technology & Therapeutics; Associate Editor, Diabetic Medicine; and Secretary-General, International Society for Pediatric and Adolescent Diabetes |
| M.M. | None | None | None | None |
| M.N.M. | Novo Nordisk, Sanofi, Eli Lilly | None | Sanofi | None |
| J.J.N. | None | None | None | Editor in Chief, Diabetes Spectrum |
| G.E.U. | None | None | Sanofi | Member, Endocrine Society Council |
| Member, American Association of Clinical Endocrinologists Board of Directors | ||||
| Editor in Chief, BMJ Open Diabetes Research & Care | ||||
| S.D.^ | None | None | Roche Diagnostic | None |
| M.K.^ | None | None | AstraZeneca, Sanofi, GlaxoSmithKline, Amgen, Boehringer Ingelheim, Novo Nordisk, Merck (Diabetes), Eisai, ZS Pharma, Glytec, Janssen, Intarcia, Novartis | None |
| W.T.C.† | None | None | Sanofi, Intarcia, Adocia | Former Editor in Chief, Diabetes Care |
| E.G.B. | None | None | None | None |
| T.D. | None | None | None | None |
| M.P.P. | None | None | None | None |
| S.U. | None | None | None | None |
| Member . | Speakers’ bureau/honoraria . | Ownership interest . | Consultant/advisory board . | Other . |
|---|---|---|---|---|
| R.R.K. | None | None | None | None |
| C.P.C. | None | None | Alnylam, Amarin, Amgen, Arisaph, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Eisai, GlaxoSmithKline, Kowa, Lipimedix, Merck, Pfizer, Regeneron, Sanofi, Takeda | None |
| A.L.C. | AstraZeneca (Women Scientists Board) | Connection Health (Volunteer Chief Medical Officer) | None | Coinvestigator, drug study by Merck Sharp & Dohme; |
| Site investigator, drug study by Boehringer Ingelheim | ||||
| D.R.C. | None | None | None | None |
| I.H.d.B. | None | None | Boehringer Ingelheim, Janssen, Ironwood | None |
| H.F. | None | None | None | Member, American Diabetes Association Primary Care Advisory Group; |
| Member, Diabetes Spectrum Editorial Board | ||||
| J.F. | None | None | None | None |
| D.M. | None | None | Insulet, Helmsely Charitable Trust | Editorial Boards, The Journal of Pediatrics and Diabetes Technology & Therapeutics; Associate Editor, Diabetic Medicine; and Secretary-General, International Society for Pediatric and Adolescent Diabetes |
| M.M. | None | None | None | None |
| M.N.M. | Novo Nordisk, Sanofi, Eli Lilly | None | Sanofi | None |
| J.J.N. | None | None | None | Editor in Chief, Diabetes Spectrum |
| G.E.U. | None | None | Sanofi | Member, Endocrine Society Council |
| Member, American Association of Clinical Endocrinologists Board of Directors | ||||
| Editor in Chief, BMJ Open Diabetes Research & Care | ||||
| S.D.^ | None | None | Roche Diagnostic | None |
| M.K.^ | None | None | AstraZeneca, Sanofi, GlaxoSmithKline, Amgen, Boehringer Ingelheim, Novo Nordisk, Merck (Diabetes), Eisai, ZS Pharma, Glytec, Janssen, Intarcia, Novartis | None |
| W.T.C.† | None | None | Sanofi, Intarcia, Adocia | Former Editor in Chief, Diabetes Care |
| E.G.B. | None | None | None | None |
| T.D. | None | None | None | None |
| M.P.P. | None | None | None | None |
| S.U. | None | None | None | None |
^
American College of Cardiology—designated representative (Section 9);
*
≥$10,000 per year from company to individual;
#
grant or contract is to university or other employer;
†
prior to joining ADA, no active disclosures.
© 2017 by the American Diabetes Association.
2017
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.
